T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

  • Jeffrey M. Critchfield
  • , Michael K. Racke
  • , Juan Carlos Zúñiga-Pflücker
  • , Barbara Cannella
  • , Cedric S. Raine
  • , Joan Goverman
  • , Michael J. Lenardo

Research output: Contribution to journalArticlepeer-review

508 Scopus citations

Abstract

Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.

Original languageEnglish (US)
Pages (from-to)1139-1143
Number of pages5
JournalScience
Volume263
Issue number5150
DOIs
StatePublished - 1994

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis'. Together they form a unique fingerprint.

Cite this